Oramed Pharmaceuticals Inc. (TLV:ORMP)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
725.00
-12.10 (-1.64%)
Jul 31, 2025, 5:24 PM IDT

Oramed Pharmaceuticals Company Description

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.

It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes.

The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses.

Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.

Oramed Pharmaceuticals Inc.
CountryUnited States
Founded2002
IndustryBiotechnology
SectorHealthcare
Employees4
CEONadav Kidron

Contact Details

Address:
1185 Avenue of the Americas
New York, Delaware 10036
United States
Phone844 967 2633
Websiteoramed.com

Stock Details

Ticker SymbolORMP
ExchangeTel Aviv Stock Exchange
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberUS68403P2039
SIC Code2836

Key Executives

NamePosition
Nadav Kidron Esq.President, Chief Executive Officer and Executive Chairman
Avraham GabayChief Financial Officer, Treasurer and Secretary
Joshua HexterChief Operating and Business Officer
Dr. Miriam Kidron Ph.D.Chief Scientific Officer and Director